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Porcine alveolar macrophagesThe present study examined the role of the p38 MAPK and JNK pathways during PRRSV infection in immor-
talized porcine alveolar macrophage (PAM) cells. Infection with PRRSV was found to progressively activate
p38 and JNK1/2 up to 36 h postinfection and then their phosphorylation levels dramatically decreased to
baseline at 48 h postinfection. In contrast, UV-inactivated PRRSV failed to trigger phosphorylation of these
SAPKs, indicating that the post-entry process is responsible for their activation. Independent treatment of
cells with a selective p38 or JNK inhibitor markedly impaired PRRSV infection, resulting in signiﬁcant reduc-
tion in synthesis of viral genomic and subgenomic RNAs, viral protein expression, and progeny virus produc-
tion. Notably, cytokine production in PAM cells infected with PRRSV was shown to be altered by inhibiting
these SAPKs. Altogether, our data suggest that the p38 and JNK signaling pathways play pivotal roles in
PRRSV replication and may regulate immune responses during virus infection.
© 2012 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV), a
pathogenic macrophage-tropic arterivirus of swine, is the etiological
agent of acute respiratory illness in young piglets and reproductive fail-
ure in pregnant sows. Although, in the last 2 decades, enormous efforts
have been undertaken to control PRRSV infection, this devastating viral
pathogen has still continued to plague most swine-producing nations,
causing a signiﬁcant economic loss to the pork industry worldwide
(Albina, 1997; Neumann et al., 2005). PRRSV is an enveloped single-
stranded positive-sense RNA virus belonging to the family Arteriviridae
in the order Nidovirales (Cavanagh, 1997; Meulenberg et al., 1993;
Snijder and Meulenberg, 1998). The PRRSV genome contains ten open
reading frames (ORFs), designated ORF1a, ORF1b, ORF2a, ORF2b, and
ORFs 3 through 7, including ORF5a. Two large ORFs 1a and 1b compris-
ing the 5′ two-thirds of the viral genome encode non-structural proteins
(nsps), whereas the remaining ORFs in the 3′ terminal region code for
structural GP2, small envelope (E), GP3, GP4, 5a, GP5, membrane (M),
and nucleocapsid (N) proteins (Dokland, 2010; Firth et al., 2011;
Johnson et al., 2011; Snijder and Meulenberg, 1998; Wu et al., 2001).
PRRSV primarily replicates in porcine alveolar macrophages
(PAMs) and in macrophages of other tissues, and can establish persis-
tent infection in the lymphoid tissues of infected pigs lasting forrights reserved.several months (Albina et al., 1994; Christopher-Hennings et al.,
1995; Duan et al., 1997; Wills et al., 2003). As a result, PRRSV infec-
tion in the natural host results in suppression of normal macrophage
functions and immune responses, which may render pigs more sus-
ceptible to secondary bacterial or viral infections causing more severe
disease than either agent alone (Allan et al., 2000; Feng et al., 2001;
Harms et al., 2001; Wills et al., 2000). Thus, PRRSV has appeared to
possess immune evasion properties capable of eliciting weak innate
immune responses likely bymodulating type 1 interferon (IFN) activity
(Buddaert et al., 1998; Luo et al., 2008; Miller et al., 2004; van Reeth et
al., 1999). Indeed, it has been recently demonstrated that PRRSV en-
codes viral products, including nsp1α, nsp1β, nsp2, nsp4, nsp11, and
N, with innate immune evasion features that are able to suppress type
1 IFN production in differentways by interferingwith various transcrip-
tion factors in the regulation of IFN expression (Beura et al., 2010; Chen
et al., 2010; Kim et al., 2010; Li et al., 2010; Sagong and Lee, 2011; Sun et
al., 2010). The impairment of type 1 IFN induction seems to be linked to
a weak adaptive immunity, which includes a delayed or slow develop-
ment of humoral and cell-mediated immune responses, leading to
viral persistence in infected pigs (Lopez and Osorio, 2004; Meier et al.,
2003; Murtaugh et al., 2002; Royaee et al., 2004).
Cells sense and respond to external stimuli by operating speciﬁc
intracellular signaling networks, such as the mitogen-activated pro-
tein kinase (MAPK) cascade pathways. As central regulators in re-
sponse to various extracellular stimuli, the MAPK pathways transmit
signals to the intracellular environment and coordinately control di-
verse cellular activities. Three distinct MAPK cascades have been
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component: extracellular signal-regulated kinases (ERK), p38 MAPK,
and c-Jun N-terminal kinases (JNK) (Roux and Blenis, 2004; Shaul
and Seger, 2007). Among these pathways, p38 MAPK and JNK, termed
stress-activated protein kinases (SAPKs), are primarily induced by
bacterial toxins, environmental stresses, and inﬂammatory cytokines
(Roux and Blenis, 2004; Tibbles and Woodgett, 1999). Upon stimula-
tion, cell surface receptors are engaged to transmit the signals to acti-
vate the p38 MAPK and JNK cascades. MEK3/6 and MEK4/7, upstream
dual activators, then phosphorylate p38 MAPK and JNK, respectively.
The activated p38 MAPK and JNK ﬁnally translocates into the nucleus
and phosphorylates a variety of transcription factors, including c-Jun,
activating transcription factor (ATF-2) and activator protein 1 (AP-1).
Activation of these downstream substrates regulates cellular tran-
scription proﬁles to induce numerous defense responses (Dong et
al., 2002; Roux and Blenis, 2004).
Viruses are completely dependent on the host cell for their repli-
cation. Thus, they have coevolved with their hosts and thus have
adapted to exploit pre-existing signal transduction networks includ-
ing the MAPK cascades to favor their ownmultiplication. Indeed, a va-
riety of viruses have been shown to activate the MAPKs upon binding,
entry, or replication and manipulate the pathways to regulate cel-
lular and/or viral gene expression for maximal virus replication
(Georgopoulou et al., 2003; Greber, 2002; Huang et al., 2011; Lim et
al., 2005; Marjuki et al., 2006; Mori et al., 2003; Pan et al., 2006;
Rahaus et al., 2004; Schümann and Dobbelstein, 2006; Si et al.,
2005; Wang et al., 2006; Wei and Liu, 2009; Wei et al., 2009; Yu et
al., 2009; Zampieri et al., 2007). We also demonstrated that the ERK
signaling pathway is activated by PRRSV replication and beneﬁcially
contributes to virus infection (Lee and Lee, 2010). However, there is
still no report regarding the activation other MAPKs including p38
and JNK, and the effects of their activation during the replication
cycle of PRRSV. In the present study, therefore, we tried to investigate
the roles of the p38 MAPK and JNK cascades in immortalized porcine
alveolar macrophage (PAM) cells upon PRRSV infection. PRRSV infec-
tion resulted in progressive activation of both p38 MAPK and JNK up
to 36 h postinfection (hpi) followed by a dramatic reduction in their
phosphorylation under basal levels at 48 hpi in PAM cells. In contrast,
UV-inactivated PRRSV was insufﬁcient to trigger phosphorylation of
these SAPKs, suggesting that active replication of PRRSV is responsi-
ble for their activation. Independent treatment of PAM cells with a se-
lective p38 or JNK inhibitor signiﬁcantly impaired PRRSV infection.
Further experiments revealed that suppression of p38 MAPK or
JNK1/2 using their speciﬁc inhibitors affects post-entry steps of the
PRRSV replication cycle, including viral genomic and subgenomic
(sg) RNA synthesis, viral protein expression, and virus production.
In addition, inhibition of these SAPKs was shown to alter expression
of cytokine genes in immortalized PAM cells infected with PRRSV. Al-
together, this study suggests that the JNK and p38 MAPK signaling
pathways play important roles in PRRSV replication and is involved
in the modulation of inﬂammatory responses during virus infection.
Results
PRRSV infection activates p38 MAPK and JNK1/2 in immortalized PAM
cells
In the present study, the roles of p38 MAPK and JNK pathways in
PRRSV replication were assessed in immortalized PAM cells during the
course of the PRRSV infection. To determine the effect of PRRSV on
these two MAPK signaling cascades, the kinetics of p38 and JNK1/2
phosphorylation was monitored in PAM-pCD163 cells infected
with PRRSV at an MOI of 1 at different times postinfection. As shown
in Fig. 1, as a negative control, little activated p38 and JNK1/2 were
detected independently in the mock infected PAM-pCD163 cells,
which were considered as the background levels of p-p38 and p-JNK1/2 possibly due to the presence of the media components. In contrast,
PRRSV infection signiﬁcantly induced both p38MAPK and JNK1/2 activ-
ities in PAM-pCD163 cells at 24 and 36 hpi that were then dramatically
declined below the baseline level by 48 hpi (Figs. 1A and B, left panels).
However, the degree of JNK1/2 phosphorylation was found to be more
progressive andmuch stronger than that of p38 phosphorylation during
the PRRSV infection. Nevertheless, these results indicate that PRRSV in-
fection triggers late robust but transient activation of these twoMAPKs.
Interestingly, new viral protein synthesis was ﬁrst evident by 12 hpi
(Figs. 1A and B),while the increased levels of p38 and JNK1/2 phosphor-
ylation began to peak after this time point, suggesting that p38 and
JNK1/2 activation is dependent on maximal PRRSV replication. These
data further allowed us to assume that p38 and JNK1/2 regulation ap-
pears at the late events of virus infection following considerable protein
production. To demonstrate this hypothesis, PAM-pCD163 cells were
treated with equal amounts of UV-irradiated inactivated virus, which
is capable of allowing viral attachment and internalization but incapa-
ble of pursuing viral gene expression (Figs. 1A and B, right panels). Un-
like infectious PRRSV, UV inactivated PRRSV did not activate both p38
and JNK1/2 in PAM-pCD163 cells. Therefore, inactivated PRRSV infec-
tion was insufﬁcient to activate the p38 and JNK signaling pathways,
suggesting that initial entry events of virus replication are dispensable
for the p38 and JNK1/2 activation.
PRRSV replication is suppressed by inhibition of p38 and JNK activation
To examine the biological importance of p38MAPK and JNK1/2 ac-
tivation in PRRSV replication, inhibitors speciﬁc for each signaling
pathwaywere used. All doses (5 and 10 μM) of the p38 and JNK inhib-
itors used in the present study did not cause detectable cell death in
the PAM-pCD163 cells determined by MTT assay (data not shown).
PAM-pCD163 cells were pretreated with the p38 inhibitor SB202190
or the JNK inhibitor SP600125 at concentrations of 5 to 10 μM or
with DMSO as a vehicle control for 1 h prior to infection. The inhibitor
or DMSO was present during the entire period of infection. Viral pro-
duction was initially measured by monitoring the cytopathic effect
(CPE) after infection and was conﬁrmed by immunoﬂuorescence
with MAb SDOW17 at 48 hpi (Fig. 2A). In the DMSO-treated control
cells, visible CPE appeared at 24 hpi and became predominant by
48 hpi and N-speciﬁc stainingwas clearly evident inmany cell clusters
indicating infection and the spread of the virus to the neighboring
cells. In contrast, the inhibitory effect of SB202190 or SP600125 on
virus propagation was readily detectable. As shown in Fig. 2A, the
p38 inhibitor SB202190 signiﬁcantly decreased PRRSV-induced CPE
and the viral gene expression only at concentration of 10 μM, whereas
the JNK inhibitor SP600125 dose-dependently suppressed PRRSV rep-
lication at concentrations of 5 and 10 μM. The number of cells expres-
sing viral antigens, quantiﬁed by the N protein staining results, was
also reduced during SB202190 or SP600125 treatment, resulting in a
maximal 80% inhibition for SP600125 at 10 μM (Fig. 2B). It appears
that the distinct effects of the two inhibitors on PRRSV infection could
be explained by the JNK activation being more robust and signiﬁcant
than the p38 activation in PRRSV-infected cells as described above.
Taken together, these data demonstrate that the p38MAPK and JNK sig-
naling pathways independently play critical roles in PRRSV replication.
To further determine atwhich point the SAPK inhibitor acted during
the PRRSV infection period, PAM-pCD163 cells were treated indepen-
dently with each inhibitor at various time points postinfection. At
48 hpi, the levels of PRRSV replication were measured indirectly as
viral antigen production by quantifying the cells expressing the N pro-
tein through IFA (Fig. 3). Treating the cells with SB202190 up to 1 h
after the time of infection resulted in about a 60% decrease in virus pro-
duction compared to the DMSO-treated control. Addition of the inhibi-
tor between 2 and 12 hpi led to 45 to 20% inhibition of virus infectivity.
Similarly, the inhibitory effect of SP600125 treated at−1, 0, and 1 hpi
was found to suppress virus production by 70–90%, while its treatment
Fig. 1. PRRSV infection activates the p38 MAPK (A) and JNK1/2 (B) signaling pathways in immortalized PAM cells. PAM-pCD163 cells were mock-infected or infected with PRRSV
(MOI of 1) (left panel) or an equal amount of UV-inactivated PRRSV (right panel). Whole cell lysates were prepared for the indicated times following PRRSV infection (hpi) and
subjected to western blot analysis with the antibody speciﬁc phosphorylated p38 (p-p38), p38, p-pJNK1/2 and JNK1/2 or the PRRSV N protein. The blot was also reacted with
mouse MAb against β-actin to verify equal protein loading. Fold changes in ratios of p-p38:total p38 and p-JNK1/2:total compared by densitometry of corresponding bands
using a computer densitometer are plotted. These data are representative of the results of three independent experiments and error bars represent standard deviations. *,
P=0.001 to 0.05; †Pb0.001.
82 Y.J. Lee, C. Lee / Virology 427 (2012) 80–89at 2–12 hpi resulted in a reduction of virus infectivity from 45 to 30%. In
contrast, no signiﬁcant impairment in virus propagation was identiﬁed
when each inhibitor was added at 24 hpi. These data revealed that the
inhibitory effect of the p38 and JNK inhibitors on PRRSV replication
was exerted primarily at the initial period of infection, suggesting that
the action of the SAPK signaling pathway is mainly in the early stage
of PRRSV infection.
Inhibition of p38 and JNK activation reduces viral progeny production
To assess whether p38 MAPK and JNK1/2 activation is necessary
for PRRSV replication, virus yield was determined during treatmentwith SAPK inhibitors. Upon infection, viral supernatants were collect-
ed at 48 hpi and viral titers were measured. As Fig. 4A shows, inhibi-
tion of p38 by SB202190 resulted in signiﬁcant suppression of virus
propagation only at a concentration of 10 μM, whereas the presence of
SP600125 reduced the release of viral progeny in a dose-dependent
manner. The peak viral titer was determined to be 1.2×108TCID50/ml
in the DMSO-treated control. However, the addition of 10 μM
SB202190 or 10 μM SP600125 decreased PRRSV titers in PAM-pCD163
cells to 9×105 and 8×103TCID50/ml (2 and 4 log reductions compared
to the control), respectively. The growth kinetics study further demon-
strated that the overall process of virus replication was signiﬁcantly
delayed when cells were treated with either SB202190 or SP600125
Fig. 2. PRRSV propagation is suppressed by inhibition of p38 MAPK or JNK1/2 activation. (A) PAM-pCD163 cells were preincubated with DMSO, SB202190 (5 and 10 μM), or
SP600125 (5 and 10 μM) for 1 h prior to infection and were mock-infected or infected with PRRSV at an MOI of 1. Virus-infected cells were further maintained for 48 h in the presence
of DMSO or inhibitors. PRRSV-speciﬁc CPEs were observed daily and were photographed at 48 hpi using an inverted microscope at a magniﬁcation of 100× (ﬁrst panels). For immunos-
taining, infected cells were ﬁxed at 48 hpi and incubated with SDOW-17 followed by Alexa green-conjugated goat anti-mouse secondary antibody (second panels). The cells were then
counterstained with DAPI (third panels) and examined using a ﬂuorescent microscope at 200× magniﬁcation. (B) Viral production in the presence of the p38 or JNK1/2 inhibitor was
measured by quantifying the number of cells expressing N proteins through IFA. Five ﬁelds at 200× magniﬁcation were counted per each condition and the total number of cells per
ﬁeld as determined by DAPI staining was similar in all ﬁelds. Values are representative of the mean of three independent experiments and error bars represent standard deviations. *,
P=0.001 to 0.05; †, Pb0.001.
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p38 and JNK pathways is required for optimal PRRSV replication within
the natural host cells.
Inhibition of p38 and JNK activation does not block virus internalization
To evaluate which step(s) of the PRRSV replication cycle was tar-
geted by treatment of the SAPK inhibitor, we started focusing on theFig. 3. Activation of p38 and JNK is required at the early stage of PRRSV infection. PAM-
pCD163 cells were pretreated with DMSO, SB202190 (10 μM), or SP600125 (10 μM) and
weremock or PRRSV(MOI of 1) infected. At the indicated times at postinfection, each inhib-
itorwas added to achieve aﬁnal concentration of 10 μM.At 48 hpi, virus-infected cellswere
ﬁxed and virus infectivity was determined by quantifying the number of cells expressing N
proteins through IFA. Data are representative of the mean of three independent experi-
ments and error bars represent standard deviations. *, P=0.001 to 0.05; †, Pb0.001.earliest steps such as virus entry upon inhibition of p38 and JNK acti-
vation. To address this issue, an internalization assay was performed
as described previously (Cai et al., 2007). PAM-pCD163 cells were in-
oculated with PRRSV at 4 °C for 1 h to allow virus attachment and fur-
ther maintained either at 4 °C or 37 °C to permit virus internalization
in the presence of each inhibitor (10 μM) or DMSO followed by treat-
ment with protease K to remove the remaining viruses on the cell
surface. The serially diluted infected cells were then subjected to in-
fectious center assay on uninfected PAM-pCD163 cell monolayers
and virus titers were measured 2 days later through IFA. As shown
in Fig. 4C, the viral titers were virtually the same in cells treated
with either inhibitor or DMSO at 37 °C and determined to be 104.66
to 104.75TCID50/ml and 104.92TCID50/ml, respectively, indicating no
difference between those cells. In contrast, only minimal viral pro-
duction of about 102TCID50/ml likely due to an inefﬁcient removal
of the bound virus was seen in cells maintained at 4 °C. These results
indicated that neither SB202190 nor SP600125 has any inhibitory ef-
fect on the virus entry process.
Treatment of SAPK inhibitors decreases viral protein translation
Following the uncoating process, like all positive-sense RNA virus-
es, the PRRSV genome is released into the cytoplasm and immediately
serves as a template for viral translation by the same cellular cap-
dependent mechanism. Early PRRSV translation produces the repli-
case polyproteins that are posttranslationally cleaved into the nsps
by the viral proteases. Subsequently, the nonstructural replicase pro-
teins mediate de novo synthesis of viral RNA, including genomic RNA
replication and sg mRNA transcription. The PRRSV structural proteins
Fig. 4. SAPK inhibitors decrease progeny virus release but do not affect virus internal-
ization. (A) PAM-pCD163 cells were pretreated with DMSO, SB202190, or SP600125 for
1 h and were mock or PRRSV infected (MOI of 1). DMSO or each inhibitor (5 and
10 μM)was present in the medium throughout the infection. At 48 hpi, the virus super-
natants were collected and virus titers were determined. (B) Growth kinetics of PRRSV
on PAM-pCD163 upon treatment with each inhibitor treatment was assessed exactly as
for panel A. At the indicated time points postinfection, culture supernatants were har-
vested and virus titers measured. (C) Virus internalization assay. PAM-pCD163 cells
were infected at an MOI of 1 at 4 °C for 1 h. After washing with cold PBS, infected
cells were maintained in the presence or absence of each inhibitor either at 4 °C or
37 °C for an additional hour. Bound but non-internalized virus particles were removed
by treatment with protease K. The infected cells were then serially diluted and plated
onto PAM-pCD163 cells in 96-well tissue culture plates. At 2 days post-incubation, in-
ternalized viruses were titrated by IFA and the 50% tissue culture infectious dose
(TCID50) was calculated. Results are expressed as the mean values from triplicate
wells and error bars represent standard deviations. *, P=0.001 to 0.05; †, Pb0.001.
Fig. 5. SAPK inhibitors impair viral protein translation. Inhibitor-treated PAM-pCD163
cells were mock-infected or infected with PRRSV (MOI of 1) for 1 h and were further
cultivated in the presence or absence of each inhibitor. At 48 hpi, cellular lysates
were collected, resolved by SDS-PAGE, transferred to a nitrocellulose membrane, and
immunoblotted by using the PRRSV-speciﬁc antibody that recognizes the viral non-
structural protein nsp2 (black bars) or structural N protein (white bars). The blot
was also reacted with mouse MAb against β-actin to verify equal protein loading.
Each viral protein expression was quantitatively analyzed by densitometry in terms
of the relative density value to the β-actin gene and inhibitor-treated sample results
were compared to DMSO-control results. Values are representative of the mean
from three independent experiments and error bars denote standard deviations. *,
P=0.001 to 0.05; †, Pb0.001.
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determine the functional mechanism of p38 MAPK and JNK1/2 activa-
tion of PRRSV infection on the postentry steps of the virus life cycle, it
was ﬁrst investigated whether nonstructural or structural protein
translation was affected by p38 and JNK inhibition. For this approach,
PAM-pCD163 cells were treated with each inhibitor for 1 h prior to
infection, and the inhibitor was also present during infection and sub-
sequent incubation periods. Expression levels of the PRRSV nsp2 and
N proteins in the presence of each inhibitor or DMSO were evaluated
at 24 hpi by western blot analysis. Production of both proteins was
evident regardless of the treatment, but synthesis of the viral non-
structural and structural proteins was drastically diminished during
each inhibitor treatment (Fig. 5). Densitometric analysis of thewestern blots exhibited that the intracellular expression of both
nsp2 and N proteins was reduced by both inhibitors and a maximal
~50% and ~70% inhibition was observed with SB202190 and
SP600125 at a concentration of 10 μM, respectively (Fig. 5). This
marked reduction was unlikely not the result of a nonspeciﬁc de-
crease on a translation mechanism since Ponceau S staining results
revealed indirectly that the expression levels of the overall cellular
proteins were found to have remained similar (data not shown).
Taken together, these results demonstrated the inhibitory effects of
SB202190 and SP600125 speciﬁcally on viral translation during
PRRSV replication.
PRRSV transcription is suppressed during treatment of SAPK inhibitors
For positive-strand RNA viruses, synthesis of the viral nonstruc-
tural proteins is required for viral RNA replication and transcription.
Thus, it is conceivable that the impaired viral protein expression
would be a result of the inhibition of viral RNA synthesis. Since
PRRSV infection produces two RNA entities including genomic and
subgenomic, we therefore determined if each SAPK inhibitor speciﬁ-
cally affects genome replication and sg mRNA transcription. To an-
swer this question, relative levels of both genomic RNA and sg
mRNA were assessed by quantitative real-time strand-speciﬁc RT-
PCR in the presence or absence of the p38 or JNK inhibitor upon
PRRSV infection. As shown in Fig. 6A, both SB202190 and SP600125
exhibited a maximal 60% and 75% reduction on viral genomic RNA
synthesis at 24 dpi, respectively, but their inhibitory effects were
less drastic at 48 dpi compared to the DMSO-treated infected cells.
In contrast, the inhibitory effects of SAPK inhibitors on sg mRNA
Fig. 6. SAPK inhibitors reduce viral RNA transcription. PAM-pCD163 cells pretreated
with DMSO, SB202190, or SP600125 were mock-infected or infected with PRRSV
(MOI of 1) for 1 h and were incubated in the presence of DMSO, SB202190, or
SP600125. Total cellular RNA was extracted at 24 hpi and 48 hpi, and strand-speciﬁc
viral genomic RNA and sg mRNA were ampliﬁed by quantitative real-time RT-PCR.
Viral positive-sense genomic RNA (A) and sg mRNA (B) were normalized to porcine
β-actin mRNA and relative quantities (RQ) of mRNA accumulation were evaluated.
Inhibitor-treated sample results were compared with DMSO-treated results. Values
are representative of the mean from three independent experiments and error bars
denote standard deviations. *, P=0.001 to 0.05; †, Pb0.001.
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detected in cells treated with SB202190 or SP600125 at a concentra-
tion of 10 μM was only about 45% and 15% of the untreated level, re-
spectively (Fig. 6B). The decreases in viral RNA levels after the addition
of each inhibitor treatment were not due to nonspeciﬁc inhibition of
transcription since the β-actin mRNA levels in all samples remained
unchanged (data not shown). Altogether, the results indicated that
both p38 and JNK inhibitors independently suppress synthesis of the
viral genomic RNA and sg mRNA.
Inhibition of p38 and JNK activation alters inﬂammatory responses during
PRRSV infection
To examine whether inhibition of the p38 or JNK signaling path-
way affects the transcriptional activation of immune-response genes
in the natural target cells upon PRRSV infection, we investigated
modiﬁcations of their expression patterns in the presence or absence
of each inhibitor. It was found that most of the immune genes regu-
lated by PRRSV infection were signiﬁcantly altered by treatment of
the cells with the p38 or JNK inhibitor compared with that obtained
in the DMSO-treated virus-infected cells (Fig. 7). Among those,
IL-1α, IL-7, IL-6, IL-8, TNF-α, and AMCF-1 mRNA levels were signiﬁ-
cantly reduced in the presence of either p38 or JNK inhibitor. Up-
regulation of IL-15 levels by PRRSV infectionwas synergically enhanced
by the inhibition of p38 activation, whereas it was decreased or
remained unchanged in the presence of the JNK inhibitor SP600125 at
24 hpi and 48 hpi, respectively. In addition, the treatment of either
p38 or JNK inhibitor resulted in a signiﬁcant reduction but an increase
in MCP-1 production at 24 hpi and 48 hpi, respectively. However, over-
all expression of cytokine genes including chemokines, interferons
(IFNs), and IFN regulatory factors (IRFs) modulated by PRRSV wassynergically elevated by suppressing p38 or JNK activation. More inter-
estingly, decreased or unchanged mRNA levels of toll-like receptor
(TLR) genes and antiviral genes upon PRRSV infectionwere signiﬁcantly
increased in infected cells treated with each SAPK inhibitor compared
with those identiﬁed in DMSO-treated infected cells. These results indi-
cated that the p38 and JNK signaling pathways regulate the cytokine
genes for immune-response during PRRSV infection.
Discussion
A variety of viruses have evolved to possess the ability to stimulate
host signaling pathways including the MAPK cascades, which can reg-
ulate a wide range of cellular functions and facilitate virus replication
(Roux and Blenis, 2004; Shaul and Seger, 2007). The present study
demonstrated for the ﬁrst time that the p38 MAPK and JNK1/2 path-
ways are required independently for active replication of PRRSV in
the natural host cells. In this report, we showed that PRRSV infection
strongly induces activation of these two SAPKs in PAM cells, suggest-
ing a pivotal role of the p38 and JNK pathways during the course of
PRRSV replication. Furthermore, treatment of cells with the p38- or
JNK-speciﬁc inhibitor resulted in signiﬁcant attenuation of postentry
steps during viral replication, as determined by lower progeny pro-
duction, diminished nonstructural and structural protein expression,
and decreased synthesis of genomic RNA and sgmRNA. Taken together,
our data indicate that the SAPK signaling pathway involving p38 and
JNK1/2 is manipulated by PRRSV and these two pathways are essential
for efﬁcient virus replication in target cells.
In contrast to infectious PRRSV, UV-inactivated virus failed to in-
duce the activation kinetics, suggesting that phosphorylation of both
p38 MAPK and JNK1/2 could not be mediated by virus entry events
including the virus-receptor interaction and uncoating process. How-
ever, it was previously found that the UN-inactivated PRRSV is sufﬁ-
cient to trigger the activation of the ERK1/2 pathway, one of the
MAPK cascades, indicating that virus entry steps may be responsible
for ERK activation (Lee and Lee, 2010). Furthermore, ERK1/2 activity
was robustly induced in the PRRSV-infected cells at 6 hpi and thereaf-
ter, progressively declined, whereas new viral protein synthesis was
ﬁrst evident by 12 hpi. These previous ﬁndings indicate that ERK1/2
activation occurs independently of maximal PRRSV replication at
the early events of virus infection prior to the considerable viral pro-
tein production. However, both p38 MAPK and JNK1/2 activities
began to be observed at 24 hpi following the considerable protein
production, suggesting that p38 and JNK1/2 activation depends on
maximal PRRSV replication at the late events of virus infection.
Since p38 and JNK are potently induced by proinﬂammatory cyto-
kines, it is tempting to speculate that the activation of the p38
MAPK and JNK1/2 signaling pathway is triggered through a mecha-
nism involving cytokines up-regulated upon PRRSV infection rather
than by active virus production.
The effect of p38 MAPK and JNK1/2 has been studied in various vi-
ruses. Although the p38 and JNK pathways are activated in response
to different viruses, the roles of their activation in virus replication
are complicated and are likely unique to each virus. In some cases,
both p38 and JNK have substantial but opposing effects on virus rep-
lication. For instance, inhibition of JNK resulted in increased varicella-
zoster virus (VZV) replication, whereas treatment of p38 led to a
strong reduction in virus replication (Rahaus et al., 2004). Singapore
grouper iridovirus (SGIV) infection was not affected by inhibition of
p38 MAPK but was suppressed signiﬁcantly by blocking JNK1/2 acti-
vation (Huang et al., 2011). On the other hand, inhibition of p38
and JNK1/2 kinases reduced porcine circovirus (PCV) replication
(Wei et al., 2009). Treatment of PAM-pCD163 cells with either the
p38 inhibitor SB202190 or the JNK inhibitor SP600125 greatly sup-
pressed PRRSV production and delayed the appearance of CPE, albeit
inhibition of JNK activation by SP600125 had a much stronger effect
on virus replication than observed in that of p38 activation. The
Fig. 7. Inhibition of p38 and JNK activation regulates immune-related genes during PRRSV infection. In the presence of DMSO or each SAPK inhibitor (10 μM), PAM-pCD163 cells
were mock-infected or infected with PRRSV at an MOI of 1. Total RNA was extracted from lysates of the infected cells at 24 hpi (left bar set) and 48 hpi (right bar set). The
mRNA level of each cytokine gene was assessed by quantitative real-time RT-PCR and normalized to that of porcine β-actin. The relative fold change of each gene (y-axis) was
then calculated between mock-infected and virus-infected cells and then compared between DMSO-treated and inhibitor-treated virus-infected cells. Data are representative of
the mean values from three independent experiments in duplicate and error bars represent standard deviations. *, P=0.001 to 0.05; †, Pb0.001.
86 Y.J. Lee, C. Lee / Virology 427 (2012) 80–89impairment of PRRSV production seemed to be directly due to a de-
crease in viral nonstructural and structural protein translation and
genomic RNA and sg mRNA synthesis, suggesting that p38 and JNK
signaling pathways contribute signiﬁcantly to the replication cycle
of PRRSV.
The activation status of kinases in the MAPK pathway is known to
have crucial impacts on the expression of immune-response genes in-
duced by virus infection (Liu et al., 2007; Salojin and Oravecz, 2007).
The feline infectious peritonitis virus (FIPV) infection-induced p38
MAPK pathway was previously found to be responsible for the pro-
duction of the pro-inﬂammatory cytokines TNF-α and IL-β (Regan
et al., 2009). Yu et al. (2009) further reported that the induction of
TNF-α and IL-6 by mouse hepatitis virus (MHV) infection is mediated
through activation of the JNK pathway but not through the ERK or
p38 pathway. In addition, upon SGIV infection, inhibition of JNK acti-
vation resulted in a signiﬁcant decrease in the transcriptional expres-
sion of TNF-α, IL-8 and IRF-1, while inhibition of p38 activation led to
a decrease in only TNF-α (Huang et al., 2011). In the present study,
we tried to assess whether inhibition of p38 MAPK or JNK1/2 activa-
tion affects the induction of cytokine genes by PRRSV in immortalized
PAM cells. Experiments using speciﬁc inhibitors provided evidence
that a variety of cytokines induced in PRRSV-infected cells are tran-
scriptionally modulated by suppressing either of the SAPK pathways.
Our results indicate that treatment with either p38 or JNK inhibitor sig-
niﬁcantly reduced infection-induced expression of pro-inﬂammatory
cytokines including IL-1α, IL-6, IL-8, and TNF-α. In contrast, inhibition
of the p38 or JNK pathway resulted in a synergic elevation in the gene
expression levels of the other cytokines and chemokines. Notably, theinduction of IFNs, IRFs, TLRs, and ISGs involved in the antiviral immune
response was speciﬁcally enhanced in the inhibitor-treated virus-
infected cells. Since PRRSV is known to possess the ability to escape
the host defense mechanism by interfering with innate immune re-
sponses, the p38 and JNK signaling pathways appear to be one of the
pivotal viral mechanisms of immune evasion by modifying the expres-
sion of immune-related genes and other cellular proteins to facilitate
virus infection. However, if inhibition of such SAPK pathways leads to
blocking the immune evasion property of PRRSV by up-regulating the
antiviral gene expression for the induction of host defenses, viral RNA
transcription and protein translation would be negatively affected,
resulting in the suppression of viral replication. Therefore, based on
our results, we propose a hypothesis that PRRSV exerts its ability to reg-
ulate innate immune responses through the activation of the p38MAPK
and JNK1/2 signaling pathways in order to favor its successful survival
and spread in the natural host.
In conclusion, our ﬁndings described here revealed that PRRSV in-
fection triggers the increased phosphorylation of both p38 MAPK and
JNK1/2 at the late period of infection in immortalized PAM cells and
activation of these two kinases is indispensable for efﬁcient PRRSV
replication in vitro. However, the viral constituents or multiplication
steps responsible for p38 and JNK activation remain undeﬁned. Al-
though our data implicated the potential correlation between the
suppression of PRRSV replication including viral RNA transcription
as well as viral protein production and the alteration of cytokine
genes upon inhibition of SAPK activation, the deﬁnite mechanism
how the virus-activated p38 and JNK regulates immune-response
genes during infection is still unclear and accordingly, would be the
87Y.J. Lee, C. Lee / Virology 427 (2012) 80–89next issue to address in future studies. Therefore, a better under-
standing of the precise roles of the activation of p38 MAPK and
JNK1/2 in PRRSV replication will provide valuable insights into the
molecular pathogenesis of PRRSV infection.
Materials and methods
Cell and virus
PAM-pCD163 cells (Lee et al., 2010) were cultured as described
previously (Lee and Lee, 2010) and maintained at 37 °C in a humidi-
ﬁed 5% CO2 incubator. The PRRSV strain VR-2332 was propagated as
described previously (Lee and Lee, 2010). Brieﬂy, PAM-pCD163 cells
were inoculated with PRRSV at a multiplicity of infection (MOI) of
0.1 for 1 h at 37 °C. The cells were further propagated for 2 days and
subjected to three rounds of freezing and thawing. Culture superna-
tants were then collected and centrifuged at 400×g (Hanil Centrifuge
FLETA 5, South Korea) for 10 min. The clariﬁed supernatant was ali-
quoted and stored at−80 °C as crude viral stocks until use. Virus inac-
tivation was performed by UV irradiation of the virus suspension with
1000 mJ/cm2 by use of a UV crosslinker (Stratagene, La Jolla, CA). Com-
plete inactivation was conﬁrmed by inoculation of the UV-treated virus
on PAM-pCD163 cells followed by staining for the PRRSV N protein as
described below and the inactivated virus was stored at−80 °C.
Reagents and antibodies
All culture reagents, media, fetal bovine serum (FBS), and Zeocin
were obtained from Invitrogen (Carlsbad, CA). The p38 MAPK inhibi-
tor SB202190 and the JNK inhibitor SP600125 were purchased from
Sigma (St. Louis, MO). Antibodies speciﬁc for p38, JNK1/2, and their
phosphorylated forms (p-p38 and p-JNK1/2) were obtained from
Cell Signaling Technology (Danvers, MA). A monoclonal antibody
(MAb; SDOW17) against the PRRSV N protein was purchased from
Rural Technologies (Brookings, SD). Rabbit polyclonal antiserum
against PRRSV nsp2/3 was a kind gift of Eric Snijder of Leiden Univer-
sity Medical Center, Leiden, The Netherlands (Kroese et al., 2008). The
anti-β-actin antibody and horseradish peroxidase (HRP)-conjugated
secondary antibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA).
Cell viability assay
The cytotoxic effect of SAPK inhibitors on PAM-pCD163 cells was
analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay (Sigma) detecting cell viability. PAM-pCD163
cells were grown at 5×104 cells/well in a 96-well tissue culture
plate with SB202190 or SP600125 treatment for 24 h. After 1 day of
incubation, 50 μl of MTT solution (1.1 mg/ml) was added to each well
and incubated for an additional 4 h. The supernatant was removed
from each well and then 150 μl of DMSO was added to dissolve the
color formazan crystal produced fromMTT. The absorbance of the solu-
tions was measured at 540 nm by an enzyme-linked immunosorbent
assay plate reader and the MTT assays were performed in triplicate.
Western blot analysis
PAM-pCD163 cells were grown in 6-well tissue culture plates for
1 day and were mock infected or infected with PRRSV at an MOI of
1 or with an equal amount of UV-inactivated virus. At the indicated
times, cells were harvested in 50 μl of lysis buffer (0.5% TritonX-100,
60 mM β-glycerophosphate, 15 mM ρ-nitro phenyl phosphate,
25 mM MOPS, 15 mM, MgCl2, 80 mM NaCl, 15 mM EGTA [pH 7.4],
1 mM sodium orthovanadate, 1 μg/ml E64, 2 μg/ml aprotinin, 1 μg/ml
leupeptin, and 1 mM PMSF) and sonicated ﬁve times for 1 s each time
on ice. Homogenates were lysed for 30 min on ice, and clariﬁed bycentrifugation at 15,800×g (Eppendorf centrifuge 5415R, Hamburg,
Germany) for 30 min at 4 °C. To examine the effect of p38 MAPK or
JNK inhibition on PRRSV replication, cells were pretreated with
SB202190 or SP600125 and then infected with PRRSV at an MOI of 1.
The virus-inoculated cells were further propagated in the presence of
SB202190 (5–10 μM), SP600125 (5–10 μM) or DMSO (0.5%) and cell ly-
sates were preparedwith lysis buffer at 48 h postinfection. Protein con-
centrations of the cell lysates were determined by a BCA protein assay
(Pierce, Rockford, IL). The cell lysates were mixed with 4× NuPAGE
sample buffer (Invitrogen) and boiled at 70 °C for 10 min. The proteins
were separated on NuPAGE 4–12% gradient Bis–Tris gel (Invitrogen)
under reducing conditions, and electrotransferred onto Immunobilon-
P (Millpore, Billerica, MA). Themembranes were blocked with 3% pow-
dered skimmilk (BD Biosciences, Belford, MA) in TBS (10 mM Tris–HCl
[pH 8.0], 150 mM NaCl) with 0.05% Tween-20 (TBST) at 4 °C for 2 h,
reacted at 4 °C overnight with primary antibodies against p-p38, p38,
p-JNK1/2, JNK1/2, PRRSVN, nsp2/3 or β-actin. The blotswere then incu-
bated with the secondary horseradish peroxidase (HRP)-labeled anti-
body (Santa Cruz Biotechnology) at a dilution of 1:5000 for 2 h at 4 °C.
Proteins were visualized by enhanced chemiluminescence (ECL) re-
agents (Amersham Biosciences, Piscataway, NJ) according to the in-
structions of the manufacturer. Ratios of phosphorylated/total p38 or
JNK1/2 were compared by densitometry of corresponding bands using
a computer densitometer with the Wright Cell Imaging Facility
(WCIF) version of the ImageJ software package (http://www.
uhnresearch.ca/facilities/wcif/imagej/). To quantitate viral protein pro-
duction, the band densities of nsp2/3 and N proteins were quantitative-
ly analyzed using densitometrywith the ImageJ program in terms of the
relative density value to β-actin gene.
Immunoﬂuorescence assay (IFA)
PAM-pCD163 cell lines grown on microscope coverslips placed in
6-well tissue culture plates were pretreated with each SAPK inhibitor,
SB202190 (5–10 μM) or SP600125 (5–10 μM), for 1 h and mock
infected or PRRSV infected at an MOI of 1. The virus-infected cells
were further grown in the presence of each inhibitor or DMSO and
at 48 hpi, were ﬁxed with 4% paraformaldehyde for 10 min at room
temperature (RT) and permeabilized with 0.2% Triton X-100 in PBS
at RT for 10 min. The cells were blocked using 1% bovine serum albu-
min (BSA) in PBS for 30 min at RT and then incubated with N-speciﬁc
MAb SDOW17 for 2 h. After being washed ﬁve times in PBS, the cells
were incubated for 1 h at RT with a goat anti-mouse secondary anti-
body conjugated with Alexa Fluor 488 (Molecular Probes, Carlsbad,
CA), followed by counterstaining with 4′,6-diamidino-2-phenylindole
(DAPI; Sigma). The coverslips were mounted on microscope glass
slides in mounting buffer (60% glycerol and 0.1% sodium azide in
PBS) and cell staining was visualized by a ﬂuorescent Leica DM IL
LED microscope (Leica, Wetzlar, Germany).
Time course of SAPK inhibitor treatment
PAM-pCD163 cells were mock infected or PRRSV infected at an
MOI of 1 as described above. At −1, 0, 1, 2, 4, 6, 8, 10, 12, or 24 hpi,
SB202190 or SP600125 was added to yield a ﬁnal concentration of
10 μM for the remainder of the time course experiment. The PRRSV-
infected and inhibitor-treated cells were further maintained and the
infection was terminated at 48 hpi by ﬁxing the monolayers with 4%
paraformaldehyde for 10 min at RT. The ﬁxed cells were subjected
to IFA to assess the presence of PRRSV infection as described above.
Virus internalization assay
The internalization assay was performed as described previously
(Cai et al., 2007). PAM-pCD163 cells grown in 6-well culture plates
were infected with PRRSV at an MOI of 1 at 4 °C for 1 h. Unbound
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ed at 4 °C or 37 °C in the presence of 10 μM of each SAPK inhibitor or
DMSO for 1 h, followed by treatment with protease K (0.5 mg/ml) at
4 °C for 45 min to remove the boundbut non-internalized virus particles.
Internalized viruses were titrated by infectious center assay with some
modiﬁcations (Lee and Lee, 2010). Brieﬂy, the infected cells were then
serially diluted in RPMI and added onto the fresh PAM-pCD163 cell
monolayers in 96-well tissue culture plates. At 2 day post-incubation,
internalized viruses were titrated through IFA as described above and
the 50% tissue culture infectious dose (TCID50) was calculated.
Quantitative real-time RT-PCR
PAM-pCD163 cells were incubated with SB202190 (5–10 μM) or
SP600125 (5–10 μM) for 1 h prior to infection and then inoculated
with PRRSV at an MOI of 1 for 1 h at 37 °C. The virus inoculumwas re-
moved and the infected cells were maintained in fresh medium con-
taining each inhibitor or DMSO for 48 h. Total RNA was extracted
from lysates of the infected cells at 24 hpi and 48 hpi by using TRIzol
reagent (Invitrogen) and treated with DNase I (TaKaRa) according to
the manufacturer's protocols. The concentrations of the extracted
RNA were measured by NanoVue spectrophotometer (GE Healthcare,
Piscataway, NJ). Quantitative real-time RT-PCR was performed using
a Thermal Cycler Dice Real Time System (TaKaRa) with gene-
speciﬁc primer sets described previously (Sagong and Lee, 2011).
The primers used in this study are described elsewhere (Lee and
Lee, 2010; Lee and Lee, submitted for publication) and primer se-
quences are available on request. The RNA levels of viral and cytokine
genes were normalized to that of porcine β-actin mRNA and relative
quantities (RQ) of mRNA accumulation were evaluated using the
2−ΔΔCt method (Livak and Schmittgen, 2001). To detect alterations
of genomic RNA and sg mRNA levels in the presence of each SAPK in-
hibitor during PRRSV infection, inhibitor-treated sample results were
compared with DMSO-treated results. To assess the effect of each inhibi-
tor on transcriptional activation of pro- and anti-inﬂammatory cytokines
in virus-infected cells, the relative fold change of each cytokine gene was
calculated between virus-infected andmock-infected PAM cells and then
compared between DMSO-treated and inhibitor-treated virus-infected
cells.
Virus titration
PAM-pCD163 cells were PRRSV infected with treatment of
SB202190 (5–10 μM), SP600125 (5–10 μM) or DMSO as described
above. The culture supernatant was collected at different time points
(6, 12, 24, 36, and 48 hpi) and stored at−80 °C. The virus titers were
measured by limiting the dilution on PAM-pCD163 cells through IFA
as described above and quantiﬁed as the TCID50/ml.
Statistical analysis
Student's t test was used for all statistical analyses and P-values of
less than 0.05 were considered statistically signiﬁcant.
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